← Ablatotech Vitals
Endocrinology EvidenceDigest

Evaluating the Role of Sleep Quality and Duration in Glycemic Control and Diabetes Management

Endocrinology · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
October 6, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Sleep quality and duration are increasingly recognized as important factors influencing glycemic control and overall diabetes management. Poor sleep, including insomnia and disrupted sleep patterns, is associated with worsened glycemic outcomes and increased diabetes-related distress in both type 1 and type 2 diabetes populations. Interventions such as cognitive behavioral therapy for insomnia (CBT-I) delivered remotely show promise in improving sleep and glycemic parameters. Incorporating sleep assessment and management into diabetes care may enhance metabolic control and patient quality of life.

Clinical bottom line

Sleep quality and duration are increasingly recognized as important factors influencing glycemic control and overall diabetes management. Poor sleep, including insomnia and disrupted sleep patterns, is associated with worsened glycemic outcomes and increased diabetes-related distress in both type 1 and type 2 diabetes populations. Interventions such as cognitive behavioral therapy for insomnia (CBT-I) delivered remotely show promise in improving sleep and glycemic parameters. Incorporating sleep assessment and management into diabetes care may enhance metabolic control and patient quality of life.

What the evidence shows

Marhefková et al. (2025) compared sleep duration and timing in individuals with type 1 diabetes versus the general population, finding that diabetes is linked to altered sleep patterns that may contribute to metabolic dysregulation.

Jeon et al. (2026) used path analysis to demonstrate that sleep disturbances exacerbate diabetes-related distress, which in turn negatively impacts glycemic control, highlighting a bidirectional relationship.

Kirisri et al. (2025) conducted a randomized controlled trial showing that remotely delivered CBT-I significantly improved sleep quality and modestly reduced HbA1c in adults with type 2 diabetes, supporting behavioral interventions as feasible adjuncts.

Smyth et al. (2020) systematically reviewed clinical practice guidelines and identified consistent recommendations for routine sleep assessment in type 2 diabetes management, emphasizing its role in comprehensive care.

Botella-Serrano et al. (2022) evaluated adults with type 1 diabetes and found that poor sleep quality and short sleep duration were associated with higher glycemic variability, suggesting sleep as a modifiable factor in glucose stability.

Earlier studies, such as Priya et al. (2015), also reported correlations between reduced sleep duration and poorer glycemic control in type 2 diabetes, reinforcing the importance of sleep hygiene.

Caveats and uncertainty

Most studies are observational or small-scale interventional trials, limiting causal inference and generalizability.

Sleep disturbances in diabetes are multifactorial, influenced by neuropathy, nocturia, and psychological factors, complicating targeted interventions.

Long-term effects of sleep improvement on hard clinical outcomes such as microvascular complications remain underexplored.

Optimal screening tools and thresholds for clinically significant sleep disturbances in diabetes populations require standardization.

How this may change practice

Clinicians should incorporate routine screening for sleep quality and duration in diabetes care, using validated questionnaires or clinical interviews.

Behavioral interventions like CBT-I, including digital delivery formats, may be considered to improve sleep and glycemic outcomes, especially in patients reporting insomnia symptoms.

Addressing sleep disturbances may reduce diabetes-related distress and improve adherence to self-management.

Multidisciplinary collaboration with sleep specialists and mental health providers can optimize care for patients with complex sleep and metabolic issues.

Future guidelines may formalize sleep assessment as a standard component of diabetes management protocols.


References

  1. Marhefková N, et al. Effects of type 1 diabetes on sleep duration and timing - a comparison within the general population. Sleep Med 2025;93:106868. DOI:10.1016/j.sleep.2025.106868
  2. Jeon B, et al. Role of Sleep Disturbances and Diabetes-Related Distress on Glycemic Control: A Path Analysis. Res Nurs Health 2026;49(1):45-55. DOI:10.1002/nur.70047
  3. Kirisri S, et al. Effects of remotely-delivered cognitive behavioral therapy for insomnia in type 2 diabetes: a randomized controlled trial. Sleep Breath 2025;29(2):789-798. DOI:10.1007/s11325-025-03469-y
  4. Smyth A, et al. Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management. Diabetes Res Clin Pract 2020;170:108532. DOI:10.1016/j.diabres.2020.108532
  5. Botella-Serrano M, et al. Evaluating the influence of sleep quality and quantity on glycemic control in adults with Type 1 Diabetes. 2022. DOI:10.1101/2022.07.20.22277229
  6. Priya BH, et al. Effect of Duration and Quality of Sleep on Glycemic Control in Type 2 Diabetes Mellitus. Int J Physiol 2015;3(2):45-50. DOI:10.5958/2320-608x.2015.00047.5

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team